John Levy

511 total citations
18 papers, 343 citations indexed

About

John Levy is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, John Levy has authored 18 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 10 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in John Levy's work include Virus-based gene therapy research (13 papers), Cancer Research and Treatments (5 papers) and CRISPR and Genetic Engineering (4 papers). John Levy is often cited by papers focused on Virus-based gene therapy research (13 papers), Cancer Research and Treatments (5 papers) and CRISPR and Genetic Engineering (4 papers). John Levy collaborates with scholars based in United States, Philippines and Czechia. John Levy's co-authors include Charles J. Link, Sergei Zolotukhin, Frederick E. Domann, G. Tim Bowden, Joanne S. Finch, Donald W. Moorman, Gerardo Cornelio, Frederick L. Hall, Erlinda M. Gordon and Steven R. Kain and has published in prestigious journals such as Nature Biotechnology, Methods in enzymology on CD-ROM/Methods in enzymology and Anesthesia & Analgesia.

In The Last Decade

John Levy

17 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Levy United States 8 209 154 94 74 33 18 343
Christof M Kramm Germany 9 242 1.2× 253 1.6× 114 1.2× 61 0.8× 17 0.5× 15 389
Morris Laster Israel 8 353 1.7× 135 0.9× 40 0.4× 75 1.0× 109 3.3× 10 463
H. Kim South Korea 8 202 1.0× 191 1.2× 150 1.6× 55 0.7× 28 0.8× 9 324
Hiroaki Katagi United States 13 358 1.7× 27 0.2× 67 0.7× 65 0.9× 31 0.9× 31 574
Gábor M. Lamm Austria 8 462 2.2× 97 0.6× 54 0.6× 11 0.1× 30 0.9× 8 535
Kornelia Schriebl Austria 10 424 2.0× 99 0.6× 29 0.3× 31 0.4× 12 0.4× 12 508
Francesco Aulicino United Kingdom 11 313 1.5× 59 0.4× 48 0.5× 24 0.3× 25 0.8× 20 393
Lina Elzaouk Switzerland 8 205 1.0× 106 0.7× 124 1.3× 29 0.4× 23 0.7× 10 413
Lea Olive Tchouate Gainkam Belgium 9 346 1.7× 36 0.2× 205 2.2× 35 0.5× 8 0.2× 10 666
Joseph J. Muldoon United States 11 306 1.5× 56 0.4× 85 0.9× 17 0.2× 8 0.2× 18 408

Countries citing papers authored by John Levy

Since Specialization
Citations

This map shows the geographic impact of John Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Levy more than expected).

Fields of papers citing papers by John Levy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Levy. The network helps show where John Levy may publish in the future.

Co-authorship network of co-authors of John Levy

This figure shows the co-authorship network connecting the top 25 collaborators of John Levy. A scholar is included among the top collaborators of John Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Levy. John Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Gordon, Erlinda M., Francisco Lopez, Gerardo Cornelio, et al.. (2007). Le morte du tumour: Histological features of tumor destruction in chemo-resistant cancers following intravenous infusions of pathotropic nanoparticles bearing therapeutic genes. International Journal of Oncology. 30(6). 1297–307. 16 indexed citations
2.
Gordon, Erlinda M., Francisco Lopez, Gerardo Cornelio, et al.. (2006). Pathotropic nanoparticles for cancer gene therapy Rexin-G™ IV: Three-year clinical experience. International Journal of Oncology. 29(5). 1053–64. 29 indexed citations
3.
Gordon, Erlinda M., et al.. (2004). Molecular Engineering of “Pathotropic” Targeting for Cancer Gene Therapy. BioProcessing Journal. 3(1). 21–26.
4.
Gordon, Erlinda M., et al.. (2004). First clinical experience using a ‘pathotropic’ injectable retroviral vector (Rexin-G) as intervention for stage IV pancreatic cancer. International Journal of Oncology. 24(1). 177–85. 40 indexed citations
5.
Seregina, Tatiana, et al.. (2001). Murine retroviral vector producer cells survival and toxicity in the dog liver.. PubMed. 14(5). 643–9. 1 indexed citations
6.
Sonntag, Kai‐Christian, Sharon Germana, Steven A. Reeves, et al.. (2000). Regulated Expression of an MHC Class II Gene from a Promoter-Inducible Retrovirus. Human Gene Therapy. 11(14). 1961–1969. 2 indexed citations
7.
Mazo, Ilya, et al.. (1999). [28] Retroviral expression of green fluorescent protein. Methods in enzymology on CD-ROM/Methods in enzymology. 302. 329–341. 3 indexed citations
8.
Levy, John, et al.. (1999). [30] In Vivo retroviral transduction and expression of green fluorescent protein. Methods in enzymology on CD-ROM/Methods in enzymology. 302. 358–369. 1 indexed citations
9.
Link, Charles J., et al.. (1999). [35] Use of codon-modified, red-shifted variants of green fluorescent protein genes to study virus-mediated gene transfer. Methods in enzymology on CD-ROM/Methods in enzymology. 302. 424–437. 1 indexed citations
10.
Link, Charles J., et al.. (1997). Gene therapy for colon cancer with the herpes simplex thymidine kinase gene. Journal of Surgical Oncology. 64(4). 289–294. 22 indexed citations
11.
12.
Levy, John, et al.. (1996). Retroviral transfer and expression of a humanized, red-shifted green fluorescent protein gene into human tumor cells. Nature Biotechnology. 14(5). 610–614. 84 indexed citations
13.
14.
Domann, Frederick E., John Levy, Joanne S. Finch, & G. Tim Bowden. (1994). Constitutive ap‐1 dna binding and transactivating ability of malignant but not benign mouse epidermal cells. Molecular Carcinogenesis. 9(2). 61–66. 58 indexed citations
15.
Bowden, G. Tim, Mark A. Nelson, John Levy, Joanne S. Finch, & Peter Krieg. (1993). Molecular Mechanisms of Skin Carcinogenesis Induced by Chemicals and Ionizing Radiation. Recent results in cancer research. 128. 215–230. 2 indexed citations
16.
Bowden, G. Tim, Deborah R. Jaffe, & John Levy. (1991). Molecular Events Involved in Ionizing Radiation Induced Skin Carcinogenesis. Journal of Radiation Research. 32(SUPPLEMENT2). 226–234. 3 indexed citations
17.
Hubbard, Andrea K., John Levy, Timothy P. Roth, & A. Jay Gandolfi. (1990). Use of Structural Alterations in the Synthesis of Halothane Metabolite Antigens to Mimic Halothane-Induced Immunogen. Drug and Chemical Toxicology. 13(2-3). 93–112. 4 indexed citations
18.
Cork, R. C., et al.. (1988). SUFENTANIL INFUSION. Anesthesia & Analgesia. 67(Supplement). 39–39. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christof M Kramm Breakdown of academic impact, for papers by Morris Laster Breakdown of academic impact, for papers by H. Kim Breakdown of academic impact, for papers by Hiroaki Katagi Breakdown of academic impact, for papers by Gábor M. Lamm Breakdown of academic impact, for papers by Kornelia Schriebl Breakdown of academic impact, for papers by Francesco Aulicino Breakdown of academic impact, for papers by Lina Elzaouk Breakdown of academic impact, for papers by Lea Olive Tchouate Gainkam Breakdown of academic impact, for papers by Joseph J. Muldoon
Rankless by CCL
2026